Harbour Investments, Inc. Aptorum Group LTD Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$1.5 - $2.64 $79 - $139	-53 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.39 - $3.22 $45 - $61	-19 Reduced 26.39%	53 $0
Q2 2021 Aug 16, 2021	SELL	$2.37 - $3.43 $7 - $10	-3 Reduced 4.0%	72 $0
Q1 2021 Aug 17, 2021	BUY	$2.45 - $4.17 $176 - $300	72 Added 2400.0%	75 $0
Q1 2021 May 12, 2021	BUY	$2.45 - $4.17 $7 - $12	3 New	3 $0

Ticker APM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,265,500
Market Cap $8.62M
Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.